HRs and 95% CIs for selected arterial and venous thromboses among MGUS patients versus matched controls, stratified by M-protein concentration at diagnosis
| Type of thrombosis . | Concentration of M-protein less than 10 g/L . | Concentration of M-protein more than 10 g/L . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year follow-up . | 5-year follow-up . | 1-year follow-up . | 5-year follow-up . | |||||||||
| MGUS patients (n = 1732) . | Controls (n = 6585) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | MGUS patients (n = 1108) . | Controls (n = 4214) . | HR* (95% CI) . | MGUS patients . | Control . | HR* (95% CI) . | |
| Arterial thrombosis† | 84 | 219 | 1.5 (1.2-1.9) | 207 | 738 | 1.1 (0.9-1.3) | 63 | 154 | 1.6 (1.2-2.1) | 163 | 529 | 1.2 (1.0-1.4) |
| Venous thrombosis‡ | 16 | 18 | 3.4 (1.7-6.7) | 47 | 95 | 2.0 (1.4-2.8) | 18 | 19 | 3.6 (1.9-6.9) | 40 | 72 | 2.2 (1.5-3.2) |
| Type of thrombosis . | Concentration of M-protein less than 10 g/L . | Concentration of M-protein more than 10 g/L . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year follow-up . | 5-year follow-up . | 1-year follow-up . | 5-year follow-up . | |||||||||
| MGUS patients (n = 1732) . | Controls (n = 6585) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | MGUS patients (n = 1108) . | Controls (n = 4214) . | HR* (95% CI) . | MGUS patients . | Control . | HR* (95% CI) . | |
| Arterial thrombosis† | 84 | 219 | 1.5 (1.2-1.9) | 207 | 738 | 1.1 (0.9-1.3) | 63 | 154 | 1.6 (1.2-2.1) | 163 | 529 | 1.2 (1.0-1.4) |
| Venous thrombosis‡ | 16 | 18 | 3.4 (1.7-6.7) | 47 | 95 | 2.0 (1.4-2.8) | 18 | 19 | 3.6 (1.9-6.9) | 40 | 72 | 2.2 (1.5-3.2) |